搜尋結果
Alzheimer's drug from Eisai and Biogen rejected in Europe
Reuters· 14 小時前... for early Alzheimer's disease, saying the risk of serious brain swelling</ ... ...
Amazon’s Swelling Cash Pile Makes Conditions Ripe for Dividend
Bloomberg· 2 日前With a cash hoard that’s expected to top $100 billion this year, conditions have never been ...
Typhoon Gaemi hits Chinese seaboard, widespread flooding feared
Reuters· 1 日前Typhoon Gaemi roared into southeastern China on Thursday after churning across the Taiwan ...
What To Know About The Deadly Nipah Virus As India Races To Contain Another Outbreak
Forbes· 5 日前Health officials in India are racing to contain an outbreak of Nipah virus after a teenage boy ...
India is on alert after a fresh outbreak of the deadly Nipah virus. Here’s what you need to know
CNBC· 2 日前Bats are believed to be one of the carriers of Nipah virus, a zoonotic disease that spreads ...
Council Post: How To Navigate The Cloud’s Newest Spending Problem: GenAI
Forbes· 2 日前For years, innovation has spurred glutenous cloud spending, but it’s now swelling to new peaks ...
European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai
CNBC· 20 小時前European drug regulators on Friday rejected the Alzheimer's treatment Leqembi from Biogen ...
Leveraged Nvidia ETFs ramp up investor risk as tech turbulence hits markets
Reuters· 2 日前s tech-led selloff continues. Exchange-traded funds (ETFs) designed to magnify the daily moves ...
One dead from Nipah virus in India's Kerala state, state health minister says - English ...
metroradio.com.hk· 6 日前Authorities in southern India's Kerala state are taking preventive steps after the death of a 14-year-old boy from the Nipah ...
Biden campaign outraises and outspends Trump campaign in June
Reuters· 6 日前President Joe Biden's election campaign last month outraised and outspent his challenger ...